Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol. 2006;48:566 75. 849. Ishikawa K, Nakai S, Takenaka T, et al. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. Circu- lation. 1997;95:2368 73. 850. The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med. 1988;319:385 92. 851. Effect of verapamil on mortality and major events after acute myo- cardial infarction (the Danish Verapamil Infarction Trial II DAVIT II). Am J Cardiol. 1990;66:779 85. 852. Frishman WH, Sica DA. Calcium Channel Blockers. In: Frishman WH, Sonnenblick EH, Sica DA, editors. Cardiovascular Pharmacohera- peutics. New York: McGraw-Hill; 2003. 853. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med. 1999;341:1447 57. 854. Ezekowitz MD, Hossack K, Mehta JL, et al. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J. 1995;129:527 35. 855. Boman K, Saetre H, Karlsson LG, et al. Antianginal effect of conven- tional and controlled release diltiazem in stable angina pectoris. Eur J Clin Pharmacol. 1995;49:27 30. 856. Brogden RN, Benfield P. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease. Drugs. 1996; 51:792 819. 857. Antman E, Muller J, Goldberg S, et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med. 1980;302:1269 73. 858. Pepine CJ, Feldman RL, Whittle J, et al. Effect of diltiazem in patients with variant angina: a randomized double-blind trial. Am Heart J. 1981;101:719 25. 859. Johnson SM, Mauritson DR, Willerson JT, et al. Verapamil adminis- tration in variant angina pectoris. Efficacy shown by ecg monitoring. JAMA. 1981;245:1849 51. 860. 